Dr. Gavin Fleming Brown, MD

Dr. Brown practices at Northside Midtown Imaging - HOPD in Atlanta, Georgia.

Dr. Brown's NPI, 1710164975, was assigned on January 29, 2008. Dr. Brown graduated from Joe R. & Teresa Lozano Long School of Medicine in 2005. Dr. Brown holds Georgia license 001412.

Dr. Brown's primary practice is Northside Midtown Imaging - HOPD, at 1110 W Peachtree St NW, Atlanta, GA 30309.

Dr. Brown's primary practice is Northside Midtown Imaging - HOPD in Atlanta, Georgia. Dr. Brown is also affiliated with Northside Hospital Atlanta. The medical group on file is Select Physical Therapy. Dmand AI also links Dr. Brown to 4 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account. Dr. Brown's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brown practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Brown's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Brown is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Brown is licensed in Georgia.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Dr. Brown treats.

CMS data shows 1,941 Medicare services from Dr. Brown across 11 procedure codes in 2024, for 627 Medicare patients. Medicare paid $128,802 for them. Every service was in an office.

CMS counts 627 Medicare patients who saw Dr. Brown in 2024. The largest group is 75 to 84, with 290 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brown's median patient age at 71, with 58% women.

In 2024, Dr. Brown wrote 4,514 Medicare Part D claims for 665 patients. 83% of them were for generic drugs. CMS names the drug for 4,073 of them, across 84 drugs with 11 or more claims each, at $6,166,884 in total drug cost. In 2023, CMS named 3,898 claims across 78 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Brown for performance year 2024, reported as part of a group. Dr. Brown accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brown as offering telehealth. CMS counts 28 procedures of skin biopsy by Dr. Brown, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Brown in 2013.

CMS Open Payments shows 574 general payments to Dr. Brown from 72 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Alexion Pharmaceuticals, Inc. paid the most, $34,281.

Dr. Brown graduated from Joe R. & Teresa Lozano Long School of Medicine in 2005. Dr. Brown is a member of AAN, AANEM and AMA.

Dr. Brown is in network with 10 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.